Keymed Biosciences Inc. (2162)
Market Closed
11 Aug, 08:00
HKEX 
82. 65
HKD +0.75
+0.9158%
11.21B Market Cap
- P/E Ratio
- Div Yield
3.33M Volume
0 Eps
81.9 HKD
Previous Close Want to track 2162 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Keymed Biosciences Inc. (2162) Statistics
Valuation metrics
Market Cap 11.21B
Enterprise value 20.95B
Trailing P/E (ttm) -39.93
Forward P/E -
PEG ratio 0.58
Price/Sales (ttm) 29.05
Price/Book (mrq) 7.56
Enterprise Value/Revenue 29.39
Enterprise Value/EBITDA -40.54
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.42M
Average volume (90 days) 2.95M
Price summary
52-Week low 44.66
52-Week high 89.75
Beta -
50-Day moving average 77.6
200-Day moving average 65.4
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.72%
Operating margin -0.83%
Operational effectiveness
Return on assets -0.12%
Return on equity -0.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.39
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.72
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.58
Total debt (mrq) -
Total Debt/Equity (mrq) 0.28
Current ratio (mrq) 2.9%
Book value per share (mrq) 9.29
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
